High-level expression of oncogenes in Escherichia coli.

Gene Amplif Anal

Laboratory of Molecular Oncology, National Cancer Institute, Bethesda, Maryland 20205.

Published: March 1989

A plasmid, pJL6, was constructed that contains a unique Cla I site 12 codons beyond the bacteriophage lambda cII gene initiation codon, as well as an adjacent unique Hind III site. These sites allowed us to fuse the sequences from the avian myelocytomatosis virus (MC29) v-myc gene, the avian myeloblastosis virus (AMV) v-myb gene, and the Harvey murine sarcoma virus (Ha-MuSV) v-ras gene to the amino-terminal portion of the cII gene. Transcription of the hybrid genes is controlled from the lambda PL promoter. When this promoter is derepressed, E. coli cells harboring the chimeric plasmid produce levels of fusion proteins that amount to over 5% of total cellular protein. Antibodies raised by the cII-myc fusion protein form an immunoprecipitate with the MC29 gene product, P110gag-myc. The cII-ras fusion protein is precipitated by monoclonal antibodies directed toward the Ha-MSV p21ras, binds GDP, and is capable of autophosphorylation.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cii gene
8
fusion protein
8
gene
6
high-level expression
4
expression oncogenes
4
oncogenes escherichia
4
escherichia coli
4
coli plasmid
4
plasmid pjl6
4
pjl6 constructed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!